Loading clinical trials...
Loading clinical trials...
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Conditions
Interventions
DS-5565
Locations
276
United States
Birmingham, Alabama, United States
Mobile, Alabama, United States
Phoenix, Arizona, United States
Anaheim, California, United States
Fresno, California, United States
Fresno, California, United States
Start Date
February 4, 2015
Primary Completion Date
April 19, 2017
Completion Date
April 19, 2017
Last Updated
July 23, 2020
Lead Sponsor
Daiichi Sankyo
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions